Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2002
09/18/2002CN1370046A Fungicides
09/18/2002CN1369484A Process for separating and purifying ebormycine from fermented myxobacterium liquid
09/18/2002CN1091103C Compounds of carbostyrils and their prepn. and use
09/17/2002US6452014 Thiazolidinedione compounds
09/17/2002US6452013 For treating conditions which are related to impairment of gastric emptying
09/17/2002US6451988 An azo compound and a metal complex which are synthesized with the naphthol derivative
09/17/2002US6451842 Cyclic amine derivatives and their use as drugs
09/17/2002US6451822 3-(Amino- or aminoalkyl)pyridinone derivatives and their use for the treatment of HIV related diseases
09/17/2002US6451821 Use of 2-aminothiazoline derivatives as inhibitors of inducible no-synthase
09/17/2002US6451814 Heterocyclic β-3 adrenergic receptor agonists
09/17/2002US6451802 S-oxide lipid lowering compounds
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
09/17/2002CA2048096C N-benzyl-indoles
09/12/2002WO2002070739A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
09/12/2002WO2002070540A2 Peptide deformylase inhibitors
09/12/2002WO2002070520A1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands
09/12/2002WO2002070519A1 Monobactams as cathepsin k inhibitors
09/12/2002WO2002070516A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
09/12/2002WO2002070511A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
09/12/2002WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof
09/12/2002WO2002070491A1 Nitrogenous heteroaromatic ring derivative having hiv integrase inhibitory activity
09/12/2002WO2002070487A1 Substituted quinolinecarboxamides as antiviral agents
09/12/2002WO2002070486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
09/12/2002WO2002070484A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
09/12/2002WO2002070483A1 Heterocyclic diamide invertebrate pest control agents
09/12/2002WO2002070479A1 N-4-piperidinyl compounds as ccr5 modulators
09/12/2002WO2002070469A2 Selective pde3b inhibitors and use of the same in therapy
09/12/2002WO2002069972A2 Triazole compounds and the use thereof in the prophylaxis and therapy of neurodegenerative diseases, cerebral trauma and cerebral ischemia
09/12/2002WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
09/12/2002WO2002069968A1 New use
09/12/2002WO2002069901A2 Cathepsin cysteine protease inhibitors
09/12/2002WO2001096334A3 Heteroarylalkanoic acids as integrin receptor antagonists
09/12/2002WO2001012600A9 INHIBITORS OF FACTOR Xa
09/12/2002US20020128278 Inhibit some of the ill effects caused by diabetes or by aging; preventing premature aging, rheumatoid arthritis, Alzheimer's disease, uremia, neurotoxicity, atherosclerosis and spoilage of proteins in food
09/12/2002US20020128270 Treating stroke, arhtritis, cancer, tissue ulceration, decubitis ulcer, restenosis, periodontal disease, epidermolysis bullosa, scleritis, psoriasis, AIDS, sepsis, and septic shock.
09/12/2002US20020128262 Styrylbenzodiazepines
09/12/2002US20020128232 Heterocyclic angiogenesis inhibitors
09/12/2002US20020127428 Organic light emitting displays and new fluorescent compounds
09/12/2002DE10110747A1 Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use
09/12/2002CA2440100A1 New use
09/12/2002CA2440038A1 Substituted 2-oxy-3,5-dicyano-4-aryl-6-aminopyridines and use thereof
09/12/2002CA2439849A1 Antagonists of mcp-1 function and methods of use thereof
09/12/2002CA2439666A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
09/12/2002CA2439176A1 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
09/12/2002CA2437840A1 Heterocyclic diamide invertebrate pest control agents
09/12/2002CA2437594A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
09/12/2002CA2433467A1 Substituted quinolinecarboxamides as antiviral agents
09/12/2002CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
09/11/2002EP1238975A1 Difluoromethyltriazolone compounds, use of the same and intermediates for the production thereof
09/11/2002EP1238970A1 Cycloamine ccr5 receptor antagonists
09/11/2002EP1237889A1 Antibiotic sultam and sultone derived oxazolidinones
09/11/2002EP1237888A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
09/11/2002EP1237887A1 9-(piperazinylalkyl)carbazoles as bax-modulators
09/11/2002EP1237875A1 Substituted imidazole neuropeptide y y5 receptor antagonists
09/11/2002EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
09/11/2002EP1237862A1 Succinate compounds, compositions and methods of use and preparation
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002EP0934309B1 New pyridyl alkane acid amides as cytostatics and immunosuppressives
09/11/2002EP0912504B1 Oxazolidine ester
09/11/2002EP0731788B1 Prolyl endopeptidase inhibitors
09/11/2002EP0668860B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
09/11/2002CN1368972A Nonsteroid IL-5 inhibitor, its preparation method and medical composition containing the inhibitor
09/11/2002CN1368883A Method for reducing serum glucose and trigluceride and inhibiting vascular formation by indolealkanoic acids
09/11/2002CN1090631C Heterocyclic compounds, preparation process thereof and medicinal composition containing same
09/11/2002CN1090624C Herbicidalor fungicidal sulphonylaminocarbonyltria with hologenated alk(en) oxy substitutuents
09/10/2002US6448405 Coupling a 2-halo-5-nitrobenzoic acid and a 2-methoxyphenyl boronic acid; cyclizing to a nitrobenzocoumarin; reducing to the amine; converting to a coumarino(3,4-f)quinoline; reduction to a 5h-chromeno(3,4-f)quinoline
09/10/2002US6448396 Compounds useful as neuro-protective agents
09/10/2002US6448281 Inhibitors of hepatitis c virus replication; treatment of hepatitis c
09/10/2002US6448273 Such as 2,6-dimethoxymethyl-1-methyl-3-benzyloxpyridin-4(1h)-one; treating disorders associated with iron distribution and iron dependant parasites; reduced levels of active agent; selective targeting to tissues and liver; metabolic stability
09/10/2002US6448272 Myt1 kinase inhibitors
09/10/2002US6448270 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
09/10/2002US6448259 Cycloalkyl-4-oxonicotinic carboxamides; agonists, antagonists or inverse agonists for gamma aminobutyric acid binding site, the benzodiazepine receptor; anxiety, sleep and seizure disorders sedative, anxiolytic and anticonvulsant activity
09/10/2002US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor
09/10/2002US6448247 Tachykinin receptor antagonist; especially to the receptors for substance p (which receptors are generally referred to as ?neurokinin 1 receptors?)
09/10/2002US6448246 Compounds that bind with high selectivity and high affinity to the benzodiazepine site of gaba.sub.a receptors
09/10/2002US6448244 Broad-spectrum antifungals, against which there is no existing resistance and which can be administered intravenously or transungually
09/10/2002US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia
09/10/2002US6448203 Substituted aryluracils
09/10/2002US6448201 Benzoylcyclohexanediones and benzoylpyrazoles, their preparation, and their use as herbicides and plant growth regulators
09/10/2002CA2240946C Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors
09/10/2002CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase
09/06/2002WO2002068417A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
09/06/2002WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002WO2002068410A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
09/06/2002WO2002068409A1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
09/06/2002WO2002068406A2 Substituted amine derivatives and their use for the treatment of angiogenesis
09/06/2002WO2002068388A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists
09/06/2002WO2002067939A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
09/06/2002WO2002067869A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists
09/06/2002WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/06/2002WO2002067684A1 Pyridyl pyrimidines for use as pesticides
09/06/2002WO2002067675A2 Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides and insecticides
09/06/2002WO2002043716A3 Method for regulating prostate gland volume with insulin sensitizers
09/06/2002WO2002028857A8 Polymorphs of pioglitazone hydrochloride and their use as antidiabetics
09/06/2002WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/06/2002WO2002012534A3 Bio-intermediates for use in the chemical synthesis of polyketides
09/06/2002WO2002008475A3 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/06/2002WO2001090071A3 Substituted iminoazines used as herbicides
09/06/2002CA2439265A1 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function